Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03846492Not ApplicableActive Not Recruiting

Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS

Role: collaborator

NCT05661084Not ApplicableRecruiting

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

Role: collaborator

NCT05508841Not ApplicableRecruiting

Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation

Role: collaborator

NCT03938870Completed

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Role: collaborator

NCT03474302Not ApplicableCompleted

Program for African American Cognition & Exercise

Role: collaborator

All 5 trials loaded